Fasting FDG PET compared to MPI SPECT in cardiac sarcoidosis

Journal of Nuclear Cardiology

Volumn 18, Issue 2, 2011, Pages 371-374

  Brancato, Scott C ^a   Arrighi, James A ^a  

^a RHODE ISLAND HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; FLUORODEOXYGLUCOSE F 18; PREDNISONE; TETROFOSMIN TC 99M;

AGED; ARTICLE; BRAIN DISEASE; CASE REPORT; DEATH; DIET RESTRICTION; HEART CATHETERIZATION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE ISCHEMIA; HEART SARCOIDOSIS; HUMAN; IMAGE ANALYSIS; INTERMETHOD COMPARISON; LUNG SARCOIDOSIS; MALE; MEDICAL ASSESSMENT; MITRAL VALVE REGURGITATION; MYOCARDIAL PERFUSION IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RESPIRATORY FAILURE; SARCOIDOSIS; SEPSIS; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TRANSTHORACIC ECHOCARDIOGRAPHY; TREATMENT OUTCOME;

AGED; CARDIOMYOPATHIES; FLUORODEOXYGLUCOSE F18; HUMANS; MALE; MYOCARDIAL PERFUSION IMAGING; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; SARCOIDOSIS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 79958080434     PISSN: 10713581     EISSN: 15326551     Source Type: Journal    
DOI: 10.1007/s12350-011-9347-2     Document Type: Article

References (13)

1. Kim JS, Judson MA, Donnino R, Gold M, Cooper LT Jr, Prystowsky EN, et al. Cardiac sarcoidosis. Am Heart J 2009;157(1):9-21.
2. Ishimaru S, Tsujino I, Takei T, Tsukamoto E, Sakaue S, Kamigaki M, et al. Focal uptake on 18F-fluoro-2-deoxyglucose positron emission tomography images indicates cardiac involvement of sarcoidosis. Eur Heart J 2005;26:1538-43. (Pubitemid 41373496)
3. Mana J. Nuclear imaging. 67Gallium, 201thallium, 18F-labeled fluoro-2-deoxy-D-glucose positron emission tomography. Clin Chest Med 1997;18:799-811. (Pubitemid 27525442)
4. Cheong BY, Muthupillai R, Nemeth M, Lambert B, Dees D, Huber S, et al. The utility of delayed-enhancement magnetic resonance imaging for identifying nonischemic myocardial fibrosis in asymptomatic patients with biopsy-proven systemic sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 2009;26:39-46.
5. Barneveld PC, van Leeuwen C, van Isselt JW. Scintigraphic demonstration of myocardial sarcoidosis: The added value of single-photon emission computed tomography. J Nucl Cardiol 1997;4:256-7. (Pubitemid 27299872)
6. Eguchi M, Tsuchihashi K, Hotta D, Hashimoto A, Sasao H, Yuda S, et al. Technetium-99m sestamibi/tetrofosmin myocardial perfusion scanning in cardiac and noncardiac sarcoidosis. Cardiology 2000;94:193-9. (Pubitemid 32250150)
7. Ohira H, Tsujino I, Ishimaru S, Oyama N, Takei T, Tsukamoto E, et al. Myocardial imaging with 18F-fluoro-2-deoxyglucose positron emission tomography and magnetic resonance imaging in sarcoidosis. Eur J Nucl Med Mol Imaging 2008;35:933-41.
8. Tellier P, Valeyre D, Nitenberg A, Foult JM, Bedig G, Battesti JP. Cardiac sarcoidosis: Reversion of myocardial perfusion abnormalities by dipyridamole. Eur J Nucl Med 1985;11:201-4. (Pubitemid 16233601)
9. Le Guludec D, Menad F, Faraggi M, Weinmann P, Battesti JP, Valeyre D. Myocardial sarcoidosis. Clinical value of technetium-99m sestamibi tomoscintigraphy. Chest 1994;106:1675-82. (Pubitemid 24375125)
10. Okumura W, Iwasaki T, Toyama T, Iso T, Arai M, Oriuchi N, et al. Usefulness of fasting 18F-FDG PET in identification of cardiac sarcoidosis. J Nucl Med 2004;45:1989-98. (Pubitemid 47611626)
11. Nishiyama Y, Yamamoto Y, Fukunaga K, Takinami H, Iwado Y, Satoh K, et al. Comparative evaluation of 18F-FDG PET and 67 Ga scintigraphy in patients with sarcoidosis. J Nucl Med 2006;47:1571-6.
12. Mehta D, Lubitz SA, Frankel Z, Wisnivesky JP, Einstein AJ, Goldman M, et al. Cardiac involvement in patients with sarcoidosis: Diagnostic and prognostic value of outpatient testing. Chest 2008;133:1426-35. (Pubitemid 351893001)
13. Langah R, Spicer K, Gebregziabher M, Gordon L. Effectiveness of prolonged fasting 18f-FDG PET-CT in the detection of cardiac sarcoidosis. J Nucl Cardiol 2009;16:801-10.